Breakthrough in Digital Health
Apple will introduce a new hypertension detection feature on its smartwatch next week, following clearance from the U.S. Food and Drug Administration (FDA). The development marks a major milestone in wearable health technology, expanding Apple’s role in preventive care.
How the Feature Works
Unveiled during Apple’s September 9 event, the blood pressure monitoring tool will leverage the smartwatch’s optical heart sensor. It will track how blood vessels respond to heartbeats over 30 days. According to Apple, while the system will not diagnose every case of hypertension, it could alert nearly one million people globally who may otherwise go undiagnosed.
Global Rollout and Device Compatibility
The feature will be available across 150 countries, highlighting Apple’s intent to position the smartwatch as a global health companion. It will be accessible on the Apple Watch Series 9, Series 10, Series 11, and the premium Ultra 2 and Ultra 3 models.
Expanding Apple’s Health Ecosystem
This launch follows Apple’s growing investment in health monitoring. The new capability adds to existing tools like ECG monitoring, fall detection, and blood oxygen measurement, reinforcing the company’s push to make its smartwatch a frontline health device.
Apple and the FDA have yet to issue official statements on the announcement. However, analysts believe the feature could significantly influence both consumer adoption and healthcare practices, particularly in preventive cardiology.
The company also used the September 9 event to unveil a refreshed iPhone lineup, including the slimmer iPhone Air.
